Advertisement

Digestive Diseases and Sciences

, Volume 56, Issue 10, pp 2865–2870 | Cite as

Expression of IFN-γ and IL-4 in the Esophageal Mucosa of Patients with Reflux Esophagitis and Barrett’s Esophagus and Their Relationship with Endoscopic and Histologic Grading

  • Ying-Qiang Zhong
  • Ying Lin
  • Zhe Xu
Original Article

Abstract

Introduction

This study investigated the expression of interferon-γ (IFN-γ) and interleukin-4 (IL-4) in the esophageal biopsies from patients with reflux esophagitis (RE) and Barrett’s esophagus (BE) and their relationships with endoscopic grading and histologic grading.

Methods

Ninety individuals were recruited (30 RE, 30 BE, and 30 normal control) and underwent upper gastrointestinal endoscopy with esophageal biopsy. Immunohistochemistry was used to semi-quantitatively detect the expression of IFN-γ and IL-4 in the specimens.

Results

IFN-γ was overexpressed in BE and RE compared with the control (P < 0.01), whereas IL-4 was up-regulated in BE compared with RE and control (P < 0.01). A positive correlation between the level of IFN-γ and the endoscopic grading (r = 0.509, P < 0.01) and histologic grading of RE (r = 0.493, P < 0.01) was observed.

Conclusions

Th1 and Th2 immune responses play different roles in the development of RE and BE. Th1 immune response is the major pathway for RE development, whereas both Th1 and Th2 immune responses are implicated in BE pathogenesis. The expression of IFN-γ is associated with the endoscopic and histologic grading of RE.

Keywords

Reflux esophagitis Barrett’s esophagus IFN-γ IL-4 Endoscopy Histology 

Notes

Acknowledgments

This work is supported by the Janssen Grant of China (YQZ, JRC01) and the Natural Science Foundation of China (YL, 30901782).

References

  1. 1.
    Shapiro M, Green C, Faybush EM, et al. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups. Aliment Pharmacol Ther. 2006;23:321–329.PubMedCrossRefGoogle Scholar
  2. 2.
    Shalauta MD, Saad R. Barrett’s esophagus. Am Fam Physician. 2004;69:2113–2118.PubMedGoogle Scholar
  3. 3.
    Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, et al. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut. 2002;50:451–459.PubMedCrossRefGoogle Scholar
  4. 4.
    Moons LM, Kusters JG, Bultman E, et al. Barrett’s oesophagus is characterized by a predominantly humoral inflammatory response. J Pathol. 2005;207:269–276.PubMedCrossRefGoogle Scholar
  5. 5.
    El Chartouni C, Rehli M. Comprehensive analysis of TLR4-induced transcriptional responses in interleukin 4-primed mouse macrophages. Immunobiology. 2010;215:780–787.PubMedCrossRefGoogle Scholar
  6. 6.
    Teloni R, Giannoni F, Rossi P, et al. Interleukin-4 inhibits cyclo-oxygenase-2 expression and prostaglandin E production by human mature dendritic cells. Immunology. 2007;120:83–89.PubMedCrossRefGoogle Scholar
  7. 7.
    Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75:163–189.PubMedCrossRefGoogle Scholar
  8. 8.
    Choi P, Reiser H. IL-4: role in disease and regulation of production. Clin Exp Immunol. 1998;113:317–319.PubMedCrossRefGoogle Scholar
  9. 9.
    Borghaei RC, Rawlings PL Jr, Mochan E. Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts. Arthritis Rheum. 1998;41:1398–1406.PubMedCrossRefGoogle Scholar
  10. 10.
    Corcoran ML, Stetler-Stevenson WG, Brown PD, et al. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J Biol Chem. 1992;267:515–519.PubMedGoogle Scholar
  11. 11.
    Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–180.PubMedCrossRefGoogle Scholar
  12. 12.
    Ismail-Beigi F, Horton PF, Pope CE II. Histological consequences of gastroesophageal reflux in man. Gastroenterology. 1970;58:163–174.PubMedGoogle Scholar
  13. 13.
    Lin Y, Buckhaults PJ, Lee JR, et al. Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer. Neoplasia. 2009;11:864–873.PubMedGoogle Scholar
  14. 14.
    Isomoto H, Wang A, Mizuta Y, et al. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol. 2003;98:551–556.PubMedCrossRefGoogle Scholar
  15. 15.
    O’Riordan JM, Abdel-latif MM, Ravi N, et al. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol. 2005;100:1257–1264.PubMedCrossRefGoogle Scholar
  16. 16.
    Yamaguchi T, Yoshida N, Tomatsuri N, et al. Cytokine-induced neutrophil accumulation in the pathogenesis of acute reflux esophagitis in rats. Int J Mol Med. 2005;16:71–77.PubMedGoogle Scholar
  17. 17.
    Yoshida N, Uchiyama K, Kuroda M, et al. Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand J Gastroenterol. 2004;39:816–822.PubMedCrossRefGoogle Scholar
  18. 18.
    Fitzgerald RC, Abdalla S, Onwuegbusi BA, et al. Inflammatory gradient in Barrett’s oesophagus: implications for disease complications. Gut. 2002;51:316–322.PubMedCrossRefGoogle Scholar
  19. 19.
    Farthing MJ, Fitzgerald R, Zhang ZW. Acid, helicobacter and immunity: a new paradigm for oesophagogastric cancer. J Physiol Paris. 2001;95:423–427.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Gastroenterology and Hepatology, Sun Yat-Sen Memorial HospitalSun Yat-Sen UniversityGuangzhouChina
  2. 2.Department of Gastroenterology and HepatologyDongguan People’s HospitalDongguanChina

Personalised recommendations